0001871604-21-000002.txt : 20211115
0001871604-21-000002.hdr.sgml : 20211115
20211115161959
ACCESSION NUMBER: 0001871604-21-000002
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211111
FILED AS OF DATE: 20211115
DATE AS OF CHANGE: 20211115
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Maranian Jeffrey R
CENTRAL INDEX KEY: 0001871604
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36866
FILM NUMBER: 211410985
MAIL ADDRESS:
STREET 1: C/O SUMMIT THERAPEUTICS INC.
STREET 2: ONE BROADWAY, 14TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Summit Therapeutics Inc.
CENTRAL INDEX KEY: 0001599298
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE BROADWAY
STREET 2: 14TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-514-7149
MAIL ADDRESS:
STREET 1: ONE BROADWAY
STREET 2: 14TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Summit Therapeutics plc
DATE OF NAME CHANGE: 20150219
FORMER COMPANY:
FORMER CONFORMED NAME: Summit Corp plc
DATE OF NAME CHANGE: 20140205
4
1
wf-form4_163701118201148.xml
FORM 4
X0306
4
2021-11-11
0
0001599298
Summit Therapeutics Inc.
SMMT
0001871604
Maranian Jeffrey R
C/O SUMMIT THERAPEUTICS INC.
ONE BROADWAY, 14TH FLOOR
CAMBRIDGE
MA
02142
0
1
0
0
VP Corporate Controller
Stock Option (right to buy)
5.28
2021-11-11
4
A
0
50000
A
2031-11-11
Common Stock
50000.0
50000
D
The option was granted on November 11, 2021. The shares underlying the option are scheduled to vest in four equal annual installments, with the first such installment occurring on November 11, 2022.
Not applicable.
/s/ Jeffrey R. Maranian
2021-11-15